Cotara: Completed Phase II enrollment

Peregrine completed enrollment of 40 GBM patients at first relapse in an open-label, U.S. and Indian Phase II trial evaluating a single 25-hour interstitial infusion of Cotara. Cotara has Orphan Drug ...